logo

For the Inventor, By the Inventor

Budapest, Hungary

György Kéri

This inventor holds 15 USPTO granted patents and 4 published patent applications and 5 EPO patents. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Vichem Chemie Kutató Kft., Virostatics Srl. Active years: 1987-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: György Kéri. Retrieved from https://idiyas.com/inventor/gyorgy-keri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 80.0

 

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 92(Granted Patents)


Company Filing History:

goldMedal3 out of 1,334 
 
Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V.
 patents
silverMedal3 out of 3 
 
Vichem Chemie Kutató Kft.
 patents
bronzeMedal2 out of 2 
 
Virostatics Srl
 patents
4. 1 out of 5 
 
Bio-Signal Corporation Ltd.
 patents
5. 1 out of 1 
 
Biosignal Kutato-Fejlesztokft
 patent
6. 1 out of 1 
 
Folligen Budapest Ltd.
 patent
7. 1 out of 1 
 
Innofinance Altalanos Innovacios Pengintezet
 patent
8. 1 out of 15 
 
Innofinance Altalanos Innovacios Penzintezet
 patents
9. 1 out of 1 
 
Innovacios Alap Kozponti Valto Es Hitelbank Rt.
 patent
10. 1 out of 6 
 
Kozponti Valto- Es Hitelbank Rt. Innovacios Alap
 patents
11. 1 out of 16 
 
Pecsi Tudomanyegyetem
 patents
12. 1 out of 157 
 
Sugen Incorporated
 patents
13. 1 out of 915 
 
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1987-2019

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 10344032 - Agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders (2019-07-09),
2. 10294218 - 4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity (2019-05-21),
3. 9951029 - Styryl quinazoline derivatives as pharmaceutically active agents (2018-04-24),
4. 9617225 - 4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity (2017-04-11),
5. 9169241 - Quinolinyloxyphenylsulfonamides (2015-10-27),
6. 9040529 - 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity (2015-05-26),
7. 8802849 - Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use (2014-08-12),
8. 8685971 - Quinolinyloxyphenylsulfonamides (2014-04-01),
9. 5700823 - Treatment of platelet derived growth factor related disorders such as (1997-12-23),
10. 5480870 - Tumor growth-inhibiting somatostatin analogues, pharmaceutical (1996-01-02),
11. 5216023 - Polyunsaturated fatty acid derivatives, pharmaceutical compositions (1993-06-01),
12. 4758552 - Gonadoliberin derivatives containing an aromatic aminocarboxylic acid in (1988-07-19),
13. 4753928 - Process for obtaining sexual products from mammals suitable for natural (1988-06-28),
14. 4647553 - Gonadoliberin derivatives and process for the preparation thereof (1987-03-03),
15. 4647552 - Process for obtaining ready for fertilization sexual products from (1987-03-03),

Title: György Kéri: Innovator in Pharmaceutical Chemistry

Introduction

György Kéri is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating various medical conditions. With a total of 15 patents to his name, Kéri's work has the potential to impact the treatment of neurogenic inflammation and neuropathic hyperalgesia.

Latest Patents

Kéri's latest patents include innovative agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders. His invention focuses on 4-phenetylamino-7H-pyrrolo[2,3-d]pyrimidine derivatives, which are identified as new drug candidates. These compounds are designed for the prevention and treatment of acute neurogenic inflammation and neuropathic hyperalgesia. Additionally, he has developed 4,6-disubstituted aminopyrimidine derivatives that exhibit anti-HIV activity, showcasing his versatility in addressing various health challenges.

Career Highlights

Throughout his career, Kéri has worked with notable companies such as Vichem Chemie Kutató Kft. and Virostatics Srl. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development. Kéri's innovative spirit and dedication to advancing medical science are evident in his extensive patent portfolio.

Collaborations

Kéri has collaborated with esteemed colleagues, including László Örfi and Zoltán Greff. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.

Conclusion

György Kéri's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, particularly in the areas of neurogenic inflammation and viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…